Nalaganje...
Control Dominating Subclones for Managing Cancer Progression and Posttreatment Recurrence by Subclonal Switchboard Signal: Implication for New Therapies
In contrast to hematological malignancies, meaningful improvements in survival statistics for patients with malignant brain tumors have not been realized in >40 years of clinical research. Clearly, a new medical approach to brain cancers is needed. Recent research has led to a new concept that ne...
Shranjeno v:
| izdano v: | Stem Cells Dev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Mary Ann Liebert, Inc.
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6916525/ https://ncbi.nlm.nih.gov/pubmed/21933025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2011.0267 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|